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Parasite growth within the erythrocyte causes dramatic alterations of host cell which on one hand facilitates nutrients acquisition
from extracellular environment and on other hand contributes to the symptoms of severe malaria. The current paper focuses on
interactions between the Plasmodium parasite and its metabolically highly reduced host cell, the natural selection of numerous
polymorphisms in the genes encoding hemoglobin and other erythrocyte proteins.
1.Introduction
Malaria is caused by approximately 200 known Plasmodium
species that infect particular lineages of primates, rodents,
birds, and reptiles. The Plasmodium species exhibit strong
speciﬁcity for certain host species while occasional jumps
between host species have been reported, and two such
jumps are thought to account for human origin of P.
vivax 53,000–265,000 years ago when an ancestral parasite
switched host from macaque monkeys to humans and
for P. knowlesi recently [1]. At present, ﬁve members of
Plasmodium species (P. falciparum, P. vivax, P. malariae, P.
ovale, and P. knowlesi) have been shown to cause human
malaria [2], and all develop through the same general life
cycle which alternates between the human host and the
anopheline mosquito. The cycle begins when a Plasmodium
infectedfemaleanophelinemosquitoprobesforabloodmeal
and injects the sporozoites into the dermis. Sporozoites then
migrate to the liver, infect hepatocytes, and remain in a
clinically silent stage. Between 5 to 16 days later depending
on the Plasmodium species, sporozoite undergoes a process
of asexual replication releasing thousands of merozoites per
infected hepatocytes into the blood. Some P. vivax and P.
ovalesporozoitesarepredestinedtodevelopintonondividing
hepatocytic forms (hypnozoites) which can remain latent
in the liver for months to years until they activate and
cause relapse infections. Once inside the bloodstream each
merozoite then invades an erythrocyte and resides in a self-
created membrane-bound vacuole, and undergoes repetitive
rounds of growth, division, and invasion in one-day (P.
knowlesi), two-day (P. falciparum, P. vivax,a n dP. ovale), or
three-day (P. malariae) periods leading to the symptoms and
complications of malaria. A subset of developing merozoites
diﬀerentiates into male and female gametocytes, and the
Plasmodium life cycle continues when both of these gameto-
cytes are taken up by the mosquitoes during blood meals. In
the mosquito midgut, gametocytes undergo fertilization and
maturation forming an infective ookinete, which migrates
through the midgut into the hemocele and develops into the
oocystinwhichsporozoitesareformed.Whenfullymatured,
the oocysts burst and release sporozoites, which migrate into
the mosquito’s salivary glands to initiate another life cycle.
The malaria-associated pathology only occurs during
the blood stage of infection, and of the ﬁve, P. falciparum
is the most deadly parasite species in humans as host
erythrocytes infected with its mature forms avoid the splenic
clearance by sequestering in capillaries and microvenules
of the brain and other vital organs, a process that is not
common with erythrocytes infected by other human malaria
parasite species. Furthermore, the parasite displays a family
of functionally redundant ligands to invade human cells
and has the ability of antigen variation to counter host2 Malaria Research and Treatment
defenses that pose a great threat to control infections by
this deadly parasite. In the course of parasite growth within
the erythrocytes, the dramatic alterations of the host cell
facilitate the acquisition of nutrients from the extracellular
environment which are not provided by the host cell, while
at the same time have the detrimental consequence of
the symptoms of severe malaria [3]. The current paper
focuses on interactions between the Plasmodium parasite
and its metabolically highly reduced host cell, appearance
of pathogen-induced novel physiological properties in a
host cell, and ﬁnally the natural selection of numerous
polymorphismsinthegenesencodinghemoglobinandother
erythrocyte proteins.
2. ParasiteInvasion of Red Blood Cell
The malaria parasite P. falciparum infects mammalian ery-
throcytes which largely lack biosynthetic pathways and is
metabolically sluggish, nutritionally deprived, and devoid of
intracellular compartments. From the time of ﬁrst contact,
it takes about half a minute for Plasmodium merozoites to
becomeinternalizedintotheerythrocytesandcanbedivided
into two distinct phases: (i) preinvasive and (ii) invasive
phase [4]. In the preinvasive phase, waves of deformation
on the erythrocyte plasma membrane initiated that soon
ceased leaving the merozoite attached to the erythrocyte
by its anterior end. The host cell’s membrane deformation
produced by erythrocytic cytoskeletal changes increases the
area of contact between merozoite and the host to assist
apical reorientation of the merozoite and is thought to be
stimulated by a localised inﬂux of calcium ions triggered
by merozoite contact [5, 6]. The duration and degree of
deformation may be dependent on closeness of the apical
end to the erythrocyte surface during initial contact as the
merozoite must reorientate and bring its penetrative apical
end in contact with the RBC prior to invasion [4]. However,
both the parasite ligands and RBC receptors involved in
this process have not been deﬁned. Murphy et al. [7]h a v e
shown the role of G protein-coupled β-adrenergic receptors
on the RBC membrane in membrane deformability during
merozoite invasion probably by cyclic AMP-induced changes
in the rigidity of underlying cytoskeleton. After deformation
ceases and the RBC resumes its normal shape, in the invasive
phase merozoite rhoptries and micronemes are thought
to secrete proteins like P. falciparum reticulocyte-binding
protein homolog (PfRh) and erythrocyte-binding antigens
(EBAs) that are involved in tight junction (TJ) formation
[8]. Following the establishment of TJ between parasite and
RBC, parasite entry to the host cell is mediated by the
movement of TJ from the apical end to posterior end of
the merozoite in a complex series of events powered by the
parasite actin-myosin motor [9]. Invasion then triggers the
host cell to undergo echinocytosis, possibly due to water loss
from the erythrocyte stimulated by an eﬄux of potassium
and chloride ions. The loss of potassium could be caused
by the opening of Gardos channels in the erythrocytic
membrane stimulated by an inﬂux of calcium ions into
the erythrocyte to reseal the erythrocyte membrane behind
the invading merozoite [4]. The postinvasive phase takes
several minutes for the iRBC to resume its normal shape
depending on whether it is multiply infected, and during
this phase merozoites transform into amoeboid ring-stage
[4, 5]. It is the infection of and multiplication within the
RBC that cause the severe symptoms of malaria, and a large
part of the intraerythrocytic development takes place in the
parasitophorous vacuole (PV), a compartment which forms
an interface between the parasite and the cytoplasm of the
host cell. Although the molecular mechanisms leading to the
formation of PV remain unknown, the exclusion of major
erythrocyte membrane proteins (such as the glycophorins or
the anion transporter band 3) from PVM and the contents
discharged of rhoptries and micronemes from the apical end
of parasite during the process of erythrocyte invasion suggest
that it is parasite derived [10, 11]. However, the observation
ofseveralerythrocytemembraneproteinsinthePVMduring
or soon after parasite invasion by Bietz et al. [12] suggests
its origin to be more complex. In the course of parasite
growth the host cell undergoes dramatic alterations and
includes establishment of nutrients transportation between
host cell cytoplasm and the parasite within PV, across
PVM and maintenance of the electrolyte balance of the
host cell. Moreover, the iRBC needs surface modulation in
order to import nutrients not readily provided by the RBCs
(such as isoleucine) and engaged in the linked processes of
sequestration and antigenic variation.
3. Transporting System of iRBC
The rapidly growing and replicating parasite has a high
nutritional demand which cannot be satisﬁed by the host
cell, and the seclusion of Plasmodium parasite within the
PV raises the need to induce new permeability pathways
(NPPs) for the acquisition of a variety of nutrients from
the extracellular milieu and from the host cell cytosol.
However,iftheRBCmembranebecomesverypermeable,the
high concentrations of haemoglobin inside would normally
encourage ﬂuid to move in, swelling and bursting the
cell. To prevent early bursting of the invaded RBC, the
parasite digests a large proportion of haemoglobin than
it needs for its own proteins [13], mostly by cytostome,
a large phagosome-like structure of the intraerythrocytic
trophozoite stage of the parasite [14]. Although hemoglobin
is the main source of amino acids for the parasite, the
uptake of several other amino acids including isoleucine,
pantothenic acid (the precursor of coenzyme A), and many
other solutes must be made from the surrounding medium
of the host cell [15, 16]. There are three proposed models
(parasitophorousductmodel,metabolicwindowmodel,and
sequential uptake model) for the acquisition of nutrients
from the extracellular milieu and in all models; the solutes
are proposed to ﬁnd access from the PV into the parasite
via transporters within the parasite plasma membrane [3,
17]. Although, a unifying model explaining the uptake of
variety of substances is a major challenge, the sequential
uptake model has recently received considerable attention
as working hypothesis [3, 17]. However, the nature of theMalaria Research and Treatment 3
proteins mediating the transport across the erythrocyte
membrane is debated and has long been thought to be
parasite derived owing to the lack of protein biosynthetic
pathway in noninfected RBC. Recent studies have shown
the involvement of endogenous host cell proteins within the
erythrocytemembraneinsolutetransportafteractivationvia
infection-induced oxidative stress and are protease sensitive
[3, 18, 19]. Studies have shown these channels as anion-
selective and either the parasite exported kinases modulate
the activity and/or substrate speciﬁcity of otherwise silent
endogenous transport proteins [20] or auxiliary parasite
proteins may be required for activation [19]. Thus, secreted
parasiteproteinscontributingtotransporteractivationcould
be potential drug targets. As well as gaining access to the
parasite many nutrients must further be transported into
organelles such as the apicoplast, which contains several
plant or bacteria-speciﬁc essential biochemical pathways,
and rely on a constant delivery of raw materials from the
parasite cytosol. However, the molecules mediating these
transport processes remain largely uncharacterized, and
further research on this may help ﬁnding a highly signiﬁcant
target for antimalarial drug development. Furthermore, the
survival of parasite under low cytosolic Ca++ concentration
in RBC poses an interesting problem to the parasite that
depends on a Ca++ signaling system to carry out its vital
functions. Gazarini et al. [21] propose that the Ca2+ ATPase
on RBC membrane responsible for pumping Ca++ across
the plasma membrane toward the extracellular space, after
membrane invagination during erythrocyte invasion, faces
the parasite and transports Ca++ from the host cytosol across
the PVM and into the PV allowing a Ca++ gradient to
form and makes Ca++ signaling within the malaria parasite
possible.ThisraisesthepossibilitythattheRBCCa++ ATPase
could be a potential site of intervention in the control of
malaria and needs modiﬁcation in the PVM to be speciﬁcally
targeted.
4. ProteinTrafﬁcking
Owing to very restricted access of host cell proteins to the
PV, there is an active unidirectional transport of parasite
proteins beyond the conﬁnes of its own plasma membrane
(PM), the PVM, and across the RBC cytosol to the host
cell plasma membrane [22]. The parasite exports about 5%
of its genome-encoded proteins into the host cell cytosol
[23]. Although the function of most of these exported
proteins is unknown, a recent gene knockout screen has
shown about 25% of exported proteins to be implicated
in essential blood-stage survival role [24], and some of
which on erythrocyte surface appear to have virulence-
associated roles, such as promoting infected cell adhesion
and/or rigidity and are the major determinants of the
unique pathogenicity of this parasite [23, 25]. Traﬃcking
of proteins within the conﬁnes of the parasite appears
to involve most of the elements of a classical vesicle-
mediated secretory pathway [22]. However, traﬃcking of
proteins beyond the conﬁnes of the parasitophorous vacuole
membrane represents a major logistical challenge. Studies
haveshownthatproteinsdestinedtoexportfromtheparasite
arrive at the PPM, released into the vacuolar lumen or
traﬃcked across the PVM either in one step at contact points
between PPM and PVM or in two steps by ﬁrst delivering
into the lumen of the vacuole followed by translocation
across the PVM [26]. In the later case, there must be a
protein conducting channel (PCC) to translocate the protein
across the PVM, and a pentapeptide RxLxE/Q/D towards the
N terminus of the protein referred to as the Plasmodium
export element (PEXEL) or vacuolar translocation signal
(VTS) directs traﬃc of proteins to locations beyond the
PVM (reviewed in [27]). Since the PEXEL motif is cleaved
within the endoplasmic reticulum (ER) of the parasite before
export with processing at the conserved leucine (L) and
acetylation of the new N-terminus that commences with
xE/Q/D, how the PEXEL/VTS acts to export the protein to its
ﬁnal destination remains unclear. Recently, de-Koning-Ward
et al. [28] have identiﬁed a translocon in the PVM called
PTEX complex, which recognize, and translocates proteins
deposited into the vacuolar space and destined for export.
However, the absence of this protein translocon machinery
even in closely related parasites proves the diﬃculty to trace
its evolutionary origin and provides an “Achilles heel” for
antimalariadrugdevelopers.TheexistenceofseveralPEXEL-
negative exported proteins (PNEPs) like the skeleton binding
protein 1 (SBP1), the membrane-associated histidine-rich
protein 1 (MAHRP1), and ring-exported protein (REX
1&2) indicates that alternative export pathways might also
exist. However, Spielmann and Gilberger [29] suggest that
despite a lack of recognizable export motifs in PNEPs, there
are similarities to mature PEXEL proteins downstream of
PEXEL cleavage suggesting that the export pathway might
accommodate both types of proteins. Clearly, experimental
data are now required to provide evidence for this hypoth-
esis. Although, mature RBC has no endogenous traﬃcking
machinery, some exported proteins destined for the erythro-
cyte cytoplasm and membrane associate with P. falciparum-
induced heterogeneous structures of convoluted ﬂotillas of
ﬂatteneddiscsthataretetheredtotheRBCmembrane,called
the maurer’s clefts (MCs), and the later play an important
roleinthetraﬃcking ofparasite proteins to thesurfaceof the
host cell [30, 31]. The parasite displays remarkable versatility
in the types of proteins exported to the MCs and in the
functions of the proteins within the MCs. Two new pathways
are suggested for export of MC resident proteins to the
MCs:(i)aPEXEL-independentpathway,wherePNEPsmight
accumulate or diﬀu s el a t e r a l l yi n t ot h eM C sa sM C sf o r m
and“bud”outofthePVM;however,additionalexperimental
evidences are needed to verify protein entry into the forming
MCs and the requirements for a “sorting signal” and
(ii) a second pathway, where some PNEPs and PEXEL-
positive exported proteins (PPEPs) cross the PVM through
a transporter and become associated with MCs, where they
translocate to the erythrocyte cytoplasm or the erythrocyte
membrane [32]. Distinct and independent from the MCs, a
tubovesicularmembranenetwork(TVN)extendingfromthe
PVM is present within the infected erythrocyte, and whether
interconnections exist between the TVN and MCs such that
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area of controversy [33, 34]. Furthermore, TVN possesses
distinct markers (such as, erythrocyte vesicle protein 1,
TVN junction protein, sphingomyelin synthase, etc.) not
found in the MCs, and inhibition of TVN formation had
no eﬀect on protein export through the MCs. Tamez et al.
[34] suggest that the parasite employs separate membrane
networks for export and import of macromolecules, and
unlike the MCs, TVN is speculated to be open to the
outside of the erythrocyte surface and is suggested to be
involved in macromolecular import. Since, the properties
of the RBCs are modiﬁed by parasite secreted proteins, for
therapeutic interventions to succeed, the crucial steps of
variant antigen transport through the MCs will need to be
identiﬁed.
5. Egressfrom RBC
DuringerythrocyticdevelopmenttheparasitestaysinthePV
throughsuccessivestageslikering,trophozoite,andschizont.
By the time, most of the RBC hemoglobin is consumed, and
afterseveral rounds of asexualdivision the schizont produces
8–24 mature merozoites which must breech the PV and RBC
membranes to escape from the host cell for another round of
RBC invasion. The merozoite egress from host erythrocyte
is a tightly regulated process mediated by multiple classes
of proteolytic enzymes. Recently, Arastu-Kapur et al. [35]
have identiﬁed two proteases, the subtilisin family serine
protease PfSUB1 and the dipeptidyl peptidase 3 (DPAP3) as
primary regulators of this process. The regulated secretion of
PfSUB1 into the PV from the exoneme a novel organelle that
is distinct from the apical organelles processes the abundant
papain-like serine repeat antigen (SERAs), which in turn act
on membrane components of the PV and RBC to initiate
host cell rupture [35, 36]. The DPAP proteases are a class of
cysteine proteases, and the DPAP3 is suggested to contribute
to parasite egress by regulating the maturation of PfSUB1.
Furthermore, the related DPAP1 protease has an essential
role in end-stage hemoglobin degradation [37], and both
class of proteases (DPAP and PfSUB1) could be a potential
target for intervention.
5.1. Host-Parasite Interactions and Malaria Severity. The
various clinical features of malaria such as impaired con-
sciousness,coma,diﬃcultyinbreathing,severeanaemia,and
multiorgan failure occur during the blood stage of infection
and thought to occur because of a combination of a high
parasite burden and the ability of parasitized erythrocytes to
adhere to vascular endothelial cells (cytoadherence), unin-
fected erythrocytes (rosetting), and platelets (clumping or
autoagglutination) [41, 42]. All these phenomena have been
linked to interactions between parasite-encoded clonally
variant antigens on the surface of parasitized erythrocytes
and host receptors. Three families of variant genes have been
characterized in P. falciparum: the var genes encoding P.
falciparum erythrocyte membrane protein 1 (PfEMP1); the
repetitive interspersed family (rif) of genes; the subtelomeric
variant open reading frame (stevor) genes. Although, rif and
stevor genes appear to be closely related, their receptors are
yet to be identiﬁed, and in most cases adhesion to host
receptors has been shown to be mediated by PfEMP1. The
var genes are tightly regulated at the transcriptional level,
expressed during the pigmented trophozoite and schizont
stages and the resultant PfEMP1 traﬃc from the Maurer’s
cleftstotheerythrocytemembranewheretheseareorganized
into knob-like structures [41]. Out of a family of 60
var genes in a parasite, only one is expressed at a time
giving rise to an antigenically distinct PfEMP1 variant [43]
and contains extracellular regions consisting of tandemly
arranged cysteine-rich domains called duﬀy-binding-like
(DBL), cysteine-rich interdomain regions (CIDR), and C2
domains [44]. The number, location, and type of DBL
and CIDR domains vary among PfEMP1 variants, and on
the basis of 5
  conserved upstream regions, the PfEMP1
can be divided into three major groups (A, B, and C)
[45]w i t hd i ﬀerent functional and clinical signiﬁcance, and
the binding domains for several host receptors, such as
CD36, complement receptor 1, and ICAM1, have been
mapped to individual DBL and CIDR domains (Figure 1).
T h es w i t c h i n go fv a rg e n ee x p r e s s i o nc a no c c u ra te a c h
new asexual blood stage cycle and allows the parasite to
modify the antigenic and functional properties of infected
erythrocytes, thereby evading immunity and altering adhe-
sion capabilities. The adhesion properties of parasite isolates
are therefore not ﬁxed, but can change in subsequent cycles
asPfEMP1expressionchangesandallowittoavoidthehost’s
normal splenic clearance mechanisms. The capacity for
phenotypic switching provides an extralevel of complexity,
and the factors that determine which var gene is selected
for transcription in each IE are currently unclear [41].
Moreover, although cell adhesive properties of IEs lead
to microvascular obstruction, metabolic disturbances, and
release of damaging inﬂammatory mediators which can
combinetocauseseverediseaseanddeathofthehumanhost,
out of the three major adhesion phenotypes (cytoadherence,
resetting, and platelets clumping), which phenotype (s)
contribute to life-threatening malaria has proved diﬃcult.
Although, all P. falciparum isolates sequester, yet not all
infections lead to life threatening disease, and current data
suggest the possibility of geographic variation in adhesion
phenotypes causing severe malaria (Table 1) which might
be due to diﬀerences in malaria transmission levels and
host immunity. In addition, the ability of P. falciparum
parasites to express selectively var2csa in pregnant hosts
mediates attachment of IEs to chondroitin sulfate A (CSA)
expressed on the syncytiotrophoblasts of the placenta and is
associated with intrauterine growth restriction, miscarriage,
and premature delivery [46, 47]. Mothers in their ﬁrst preg-
nancy are particularly susceptible to these complications;
however after several pregnancies acquired immunity to
CSA-binding PfEMP-1 molecules protects the mothers as
well as their fetuses and provides strong support for the
contribution of variant antigens to the parasite’s immune
evasionandvirulentmechanisms.IEsarealsoknowntobind
to a variety of immune system cells, which has important
immunological consequences and are beyond the scope of
this paper.Malaria Research and Treatment 5
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VCAM1 (CD106)
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Integrin avb3
Fibronectin
NCAM (CD56)
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Figure 1: (i) Erythrocytes infected with mature forms of P. falciparum parasites (pigmented trophozoites and schizonts) have the ability to
bind to vascular endothelium of various organs and tissues such as heart, lung, brain, muscle, and adipose tissue (sequestration), uninfected
erythrocytes (rosetting), and platelets (platelet-mediated clumping) thus, allowing only young ring forms of the parasite to be detected
in human peripheral blood samples. Rosetting and platelet-mediated clumping are phenotypes that are displayed by some but not all P.
falciparum isolates, and the PfEMP1 variants that mediate rosetting are predominantly of the group A type, which do not adhere to CD36.
Owing to the fact that heparan sulphate mediates binding of rosetting IEs to endothelial cells, it is unclear whether binding of IE to heparan
sulphate on endothelial cells occurs independently of rosetting, or all parasites that bind heparan sulphate form rosettes. Although three
receptors for cytoadherence have been identiﬁed for platelet clumping, the molecular mechanisms of the interaction of P. falciparum ligands
with platelets are not fully understood, and PfEMP1 is thought to be a likely candidate molecule. Furthermore, these receptors do not
form clump in all the cases and suggest the participation of distinct epitopes on these receptors or additional platelet receptors in clumping
formation.(ii)ThepredicteddomainorganizationandbindingpropertiesofPfEMP-1todiﬀerenthostreceptors.Arrowfromthereceptorsto
PfEMP1 domain indicates their respective binding sites, and for other receptors, the binding domains are yet to be identiﬁed. A: Erythrocyte,
B: Infected erythrocyte, C: Infected erythrocyte at pigmented trophozoite stage, D: Platelet, and E: Leukocyte.
Table 1: Geographic variations in malaria pathogenesis.
South East Asia Africa Ref
Low transmission in general High transmission [38]
Severe malaria aﬀects all age group Severe malaria aﬀects mostly the children under 5 yrs of age [39]
Multiorgan failure is common with seizures,
respiratory distress, and anemia being more
common in children whereas renal and hepatic
failures are in adults.
Cerebral malaria, severe anemia, and respiratory distress are common [39, 40]
Total parasite burden is associated with risk of
severe malaria and deaths
This relationship is less clear as children tolerate high parasitemias
without developing severe malaria. [38]
Rosetting is not associated with severe malaria Rosetting is associated with severe malaria [41]
Platelet-mediated clumping is associated with
severe malaria
Platelet-mediated clumping is associated with severe malaria or high
parasitemia [41]6 Malaria Research and Treatment
Table 2: Red blood cell polymorphisms and mechanism of protection against severe malaria.
Name Gene aﬀected Polymorphisms Mechanism of protection References
Invasion
Membrane proteins
Duﬀyn e g a t i v e F Y G A T A - 1m o t i f Duﬀy-negative RBCs fail to form an apical junction and
prevents invasion of P. vivax and P. knowlesi [3]
Glycophorin C
deﬁciency GYP C Exon3 deletion
Protection against EBA-140-mediated invasion by P. falciparum
parasites. Mechanism in common with other causes of
ovalocytosis
[48, 49]
Band 3 SLC4A1 27bp deletion
Resistance to invasion. Increased adhesion of P.
falciparum-infected ovalocytes to CD36, thus reducing
neurovascular binding of iRBCs in the brain
[48]
CR proteins CR1 Sl2 or McCb Reduced ability of P. falciparum—infected CR1—deﬁcient red
blood cells to form rosettes [50]
ABO ABO
GlycosylT
Polymorphisms
in exon 6 and 7
Loss of ABO Glycosyltransferase function results in the O blood
group which prevents rosette formation [51]
Replication within the RBC and/or elimination of iRBC
RBC enzymes
G6PD deﬁciency G6PD A376G/G202A
[G6PD(A–)] Early phagocytosis of iRBCs [52]
PK deﬁciency PKLR
∗About 200
variants
Reduced rate of parasite replication within RBC and enhanced
phagocytosis [53]
Hemoglobinopathies
(i) Structural variants
HbS HBB β6: glutamate to
valine
Increased sickling of parasitized erythrocytes leading to
enhanced clearance by the spleen. Reduced erythrocyte
invasion, early phagocytosis, and inhibited parasite growth
under low oxygen tension in venous microvessels. Altered
PfEMP-1 display and reduced cytoadherence of parasitized
erythrocytes Enhancement of innate and acquired immunity
[1, 54]
HbC HBB β6: glutamate to
lysine
Altered PfEMP-1 display and reduced cytoadherence of
parasitized erythrocytes [55]
HbE HBB β26: glutamate
to lysine
Unidentiﬁed membrane abnormality renders resistant to
invasion [56]
(ii) Thalassemia
α-thalassemia HBA1/HBA2 3.7-kb deletion
Reduced expression of CR1 reduces P. falciparum resetting and
confers protection against severe malaria. Increased
microerythrocyte count in homozygotes reduces the amount of
hemoglobin lost for any given parasite density, thus protecting
against severe anemia
[1]
∗Population distribution of variants are yet to be established.
5.2. Red Blood Cell Polymorphisms and Malaria. Malaria has
exerted great evolutionary pressure on the human genome
resulting in the natural selection of numerous polymor-
phisms in the genes encoding some erythrocyte surface
proteins, hemoglobin, and other eﬀectors of immunity.
In malaria-endemic areas of disease, the combined eﬀects
of very high incidence of infection and malaria-associated
deathsmostlyinyoungchildrenfavorselectionandretention
of infection-resistant genetic variants although in some
instances homozygosity for these same variants can cause
other diseases that might have otherwise disfavored their
retention [57, 58]. Genetic variants of erythrocytes aﬀecting
invasion and replication within the RBC and/or elimination
of iRBC have a major eﬀect on infection. The existence
of naturally occurring red cell variants that are deﬁcient
in speciﬁc surface proteins involved in parasite invasion
gives protection against severe malaria and includes the
red cell glycophorins (GYP), band 3, duﬀyn e g a t i v e ,C R 1
variants, and ABO group (Table 2). Of particular interest
is the ABO Glycosyltransferase (GlycosylT), a branching
enzyme that adds N-acetylgalactosamine, galactose, or nei-
ther tothe H precursor to create the major blood groups
A, B, and O, respectively. Loss of ABO GlycosylT function
results in “O” group and functional ABO enzyme (in
particular the A haplotype) have been associated with
greater risk of severe malarial anemia, implying that the O
blood group oﬀers a certain degree of protection against
malaria [51].Malaria Research and Treatment 7
The mature red blood cells depend on anaerobic
metabolism of glucose due to the lack of mitochondria and
deﬁcienciesoftwoenzymesofglucosemetabolism(Pyruvate
kinase;PKandGlucose-6-phosphatedehydrogenase;G6PD)
have been shown to protect against malaria. Recent in vitro
studies have shown that PK-deﬁcient homozygotes had
reducedrateofparasitereplicationandhadincreasedphago-
cytosis by macrophagesin both homo- and heterozygotePK-
deﬁcient mutant [53]. Although, the molecular basis of PK
deﬁciency is diverse, its population distribution has yet to be
established through systematic studies. Similarly, the G6PD
deﬁciency has been shown to be protective against malaria
probably due to the early phagocytosis of iRBCs and may
result from accelerated oxidative membrane damage in deﬁ-
cient cells with impaired antioxidant defence. Like PK deﬁ-
ciency, the G6PD deﬁciency has diverse genetic origins and
in some malaria-endemic areas was observed at increased
frequency [52].
Once inside the erythrocyte, Plasmodium parasites
degrade hemoglobin (Hb) for nutritional needs; however,
disorders of hemoglobin structure (HbS, HbC, HbE) and
production due to deletions or point mutations in the
noncoding portion of the globin genes causing inade-
quate synthesis of the α-a n dβ-globin chains (α-a n dβ-
thalassaemias resp.) have been shown to protect against
death from malaria. Although, HbAS is strongly protective
against all forms of clinical malaria, HbC variants appear
to be protective against relatively speciﬁc cerebral malaria,
and both are associated with reduced parasite densities
and increased phagocytosis of infected erythrocytes [48].
However, in HbAS, HbAC, and HbCC individuals who still
display substantial parasite densities, the mechanism for
protection against severe malaria was unknown. Recently,
the protective eﬀect of HbAS, HbAC, and HbCC variants
is attributed to the altered expression of PfEMP-1 and
reduction in binding of these iRBCs to endothelial mono-
layers and blood monocytes possibly interfering traﬃcking
and anchoring of PfEMP1, mediated by elevated levels
of membrane-bound, oxidized, and denatured hemoglobin
molecules (hemichromes) in HbS and HbC iRBCs [54,
55]. In contrast to this, the α-thalassaemia appears to be
protective against relatively speciﬁc severe malaria anaemia
and has no eﬀect on parasite densities suggesting a diﬀerent
protection mechanism. This is further supported by the
study of Williams et al. [59] who showed the negative
epistatic interactions between HbS and α-thalassaemia alle-
les when coinherited and lost their individual protective
eﬀect. Although, the mechanism of protection against
severe anemia is unknown, the observation of reduced
expression of CR1 in α-thalassaemia [60] attributes the
reduction in CR1-mediated rosetting could have some roles
and needs to be explored in further clinical studies. The
protective eﬀect of HbE variant is associated with reduced
invasion of HbE erythrocytes by Plasmodium parasites,
and the mutation frequency is very common in Southeast
Asia with up to a 70% carrier in some endemic regions
[56].
6. Conclusion
Eﬀorts made towards the eradication of malaria have so far
been unsuccessful. Owing to the conﬁnement of malaria-
associated pathology to the blood stage of infection, under-
standing of host-Plasmodium interactions at this stage is
essential to design new intervention strategies against severe
malaria. Understanding these interactions may lead to novel
therapeutic approaches based on impairment in import of
essentialnutrientsnotreadilyprovidedbytheRBCsfromthe
extracellular milieu to Plasmodium, blocking of parasite traf-
ﬁcking of proteins to the host cell surface that are crucial for
antigenicvariationsandevadinghostdefensemechanismsor
development of interventions to reverse adhesion of infected
RBCs to other human cells and inhibitors of proteases that
are likely to have signiﬁcant eﬀects on parasite metabolism
andhostcellegress.Furthermore,thecontinuingexploration
of the RBC polymorphisms and the molecular basis by
which these variants exert their protective eﬀects will be an
important source of information for the erythrocytic stage
of the disease.
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